33.99
+7.02%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About OrthoPediatrics
From its filings with the US Securities and Exchange Commission
OrthoPediatrics is based in Warsaw, Indiana. Its shares trade on Nasdaq under the ticker KIDS. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $236.3m and a net loss of $39.6m. At that date it held total assets of $508.6m and shareholders' equity of $346.6m. By business, Trauma and deformity brought in 70.4% of revenue, followed by Scoliosis at 27.9% and Sports medicine/other at 1.7%. By region, U.S. accounted for 78.9%, followed by International at 21.1%.
OrthoPediatrics Corp. (the "Company") is a Delaware corporation, headquartered in Warsaw, Indiana, and organized in November 2007. The Company’s Common Stock is traded on the Nasdaq Global Market under the symbol KIDS. OrthoPediatrics Corp. is a medical device company committed to designing, developing and marketing anatomically appropriate implants, instruments and specialized braces for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers the ability to treat children with technologies specifically designed to meet their needs. Initially organized as an Indiana limited liability company on August 31, 2006, OrthoPediatrics Corp. was converted to a Delaware corporation on November 30, 2007. We sell our specialized products, including PediLoc®, PediPlates®, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc® Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSETM Spine, BandLocTM, Pediatric Nailing Platform | Femur, Devise Rail, Orthex®, The Fassier-Duval Telescopic Intramedullary System®, SLIMTM Nail, The GAP NailTM, The Free Gliding SCFE Screw SystemTM, GIRO™ Growth Modulation System, PNP Tibia System, ApiFix® Mid-C System, Mitchell Ponseti®, VerteGlideTM, and Boston Brace 3D® specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets.
Quoted from its 10-K, filed 4 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 12 Oct 2017
- Employees
- 602
- Website
- orthopediatrics.com ↗
- Head office
- 2850 FRONTIER DRIVE, WARSAW, IN, 46582
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Accelerated filer
Leadership
Pay as last reported
- Mr. Mark ThrodahlChairman of the Board, since 2009$45,000
- Mr. David BaileyPresident, Chief Executive Officer, Director, since 2009$3.7m
- Mr. Fred HiteChief Financial Officer, Chief Operating Officer, Director, since 2015$2.6m
- Mr. Joseph HauserPresident of Trauma, Deformity and OPSB$1.7m
- Mr. Gregory OdlePresident of Scoliosis$1.6m
- Mr. Daniel GerritzenExecutive Vice President - Legal, General Counsel, Company Secretary$1.6m
- Ms. Kelly FischerDirector
- Dr. George DyerIndependent Director$180,000
- Mr. Bryan HughesIndependent Director$190,000
- Ms. Marie InfanteIndependent Director$185,000
- Mr. Jimmy McdonaldIndependent Director$180,000
- Mr. David PelizzonIndependent Director$180,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 29
- Environment
- 33
- Social
- 51
- Governance
- 3
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- OrthoPediatrics Corp is known for its continuous product innovation in the field of pediatric orthopedics. This strength allows the company to stay competitive and cater to the unique needs of pediatric patients.
- With a focus solely on pediatric orthopedics, OrthoPediatrics Corp has established itself as a leader in this niche market. This specialization enables the company to provide highly specialized and targeted solutions to its customers.
Weaknesses
- OrthoPediatrics Corp relies heavily on a few key customers for a significant portion of its revenue. This dependence poses a risk, as any loss of these customers could have a substantial negative impact on the company's financial performance.
- Despite its success in the domestic market, OrthoPediatrics Corp has a relatively limited global presence compared to some of its competitors. This limited reach may restrict the company's growth opportunities in international markets.
Opportunities
- There is a growing demand for pediatric orthopedic solutions due to an increasing focus on children's health and well-being. OrthoPediatrics Corp can take advantage of this opportunity by further expanding its product offerings and targeting new customer segments.
- OrthoPediatrics Corp can explore expansion opportunities in emerging markets, where there is a rising need for specialized orthopedic solutions for children. By entering these markets early, the company can gain a competitive advantage and establish a strong presence.
Threats
- The pediatric orthopedic industry is highly competitive, with numerous players competing for market share. OrthoPediatrics Corp faces the threat of intense competition, which could potentially impact its market position and profitability.
- The healthcare industry is subject to various regulations and compliance requirements. OrthoPediatrics Corp may face challenges in navigating these regulations, which could result in increased costs and delays in product approvals.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.